| 1 | 25825724 | ATP binding to the pseudokinase domain of JAK2 is critical for pathogenic activation. | Proc Natl Acad Sci U S A | 2015 Apr 14 |
7 |
| 2 | 27617860 | Interruption of progerin-lamin A/C binding ameliorates Hutchinson-Gilford progeria syndrome phenotype. | J Clin Invest | 2016 Oct 3 |
2 |
| 3 | 33024737 | Mesenchymal Stem Cell-Mediated Therapy of Peripheral Artery Disease Is Stimulated by a Lamin A-Progerin Binding Inhibitor. | J Lipid Atheroscler | 2020 Sep |
1 |
| 4 | 33370104 | Discovery of BMS-986202: A Clinical Tyk2 Inhibitor that Binds to Tyk2 JH2. | J Med Chem | 2021 Jan 14 |
5 |